| Stage | DCO | % of rev | INVX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $224M | 100.00% | $245M | 100.00% | INVX ×1.09 |
| Gross profit | $63M | 28.02% | $84M | 34.16% | INVX +6.1pp |
| Operating income | $28M | 12.62% | $34M | 13.79% | INVX +1.2pp |
| Pre-tax income | $25M | 11.05% | $35M | 14.46% | INVX +3.4pp |
| Net income | $20M | 9.09% | $25M | 10.22% | INVX +1.1pp |
| Stage | DCO | INVX | Gap · A − B |
|---|---|---|---|
| Revenue | $224M100.00% | $245M100.00% | INVX ×1.09 |
| Gross profit | 28.02%$63M | 34.16%$84M | INVX +6.1pp |
| Operating income | 12.62%$28M | 13.79%$34M | INVX +1.2pp |
| Pre-tax income | 11.05%$25M | 14.46%$35M | INVX +3.4pp |
| Net income |
| 9.09%$20M |
| 10.22%$25M |
| INVX +1.1pp |
No shared counterparties.